Literature DB >> 5472202

Cardiovascular effects of prostaglandins mediated by the central nervous system of the dog.

H A Lavery, R D Lowe, G C Scroop.   

Abstract

1. Prostaglandins A(1), E(1), F(1alpha) and F(2alpha) were infused into the vertebral artery of the chloralose-anaesthetized greyhound and the resulting cardiovascular responses were compared with those obtained on intravenous and intracarotid infusions in the same dose range.2. Infusions of PGF(2alpha) intravertebrally (4-64 (ng/kg)/min) caused an increase of blood pressure, tachycardia and a fall of central venous pressure. Cardiac output was increased and peripheral resistance was essentially unchanged. There was never any response to intravenous or intracarotid PGF(2alpha) infusions in this dose range.3. PGF(1alpha) was found to have similar effects to PGF(2alpha) but it was much less potent.4. PGE(1) infusions (4-360 (ng/kg)/min) into the vertebral artery caused a tachycardia which was greater than that obtained with intracarotid or intravenous infusions, but there was no significant effect on blood pressure.5. Infusions of PGA(1) caused a small fall of blood pressure accompanied by an increase of heart rate and the dose response relationships were similar for all three routes of administration.6. It is concluded that some prostaglandins can activate cardioregulatory centres within the territory of distribution of the vertebral artery. Prostaglandin F(2alpha) is the most potent of these.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5472202      PMCID: PMC1702610          DOI: 10.1111/j.1476-5381.1970.tb10359.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  The cardiovascular response to vertebral artery infusions of angiotensin in the dog.

Authors:  R D Lowe; G C Scroop
Journal:  Clin Sci       Date:  1969-12       Impact factor: 6.124

2.  Effect of prostaglandin E1 on blood pressure and heart rate in the dog. Prostaglandin and related factors 48.

Authors:  L A Carlson; L Orö
Journal:  Acta Physiol Scand       Date:  1966-05

3.  Studies on the pressor responses produced by bradykinin and kallidin.

Authors:  W J Lang; L Pearson
Journal:  Br J Pharmacol Chemother       Date:  1968-02

Review 4.  Hypotheses on physiological roles of prostaglandins.

Authors:  E W Horton
Journal:  Physiol Rev       Date:  1969-01       Impact factor: 37.312

5.  Central and reflexogenic cardiovascular actions of prostaglandin E1.

Authors:  H R Kaplan; G J Grega; G P Sherman; J P Buckley
Journal:  Int J Neuropharmacol       Date:  1969-01

6.  Inactivation of prostaglandins by the lungs.

Authors:  P J Piper; J R Vane; J H Wyllie
Journal:  Nature       Date:  1970-02-14       Impact factor: 49.962

7.  Spontaneous and evoked release of prostaglandins from cerebral cortex of anesthetized cats.

Authors:  P W Ramwell; J E Shaw
Journal:  Am J Physiol       Date:  1966-07

8.  A note on the cardiovascular and metabolic effects of prostaglandin A-1. Prostaglandin and related factors 61.

Authors:  S Bergström; L A Carlson; L Orö
Journal:  Life Sci       Date:  1967-03-01       Impact factor: 5.037

9.  Biological effects of an unsaturated trihydroxy acid (PGF2alfa) from normal swine lung.

Authors:  E ANGGARD; S BERGSTROM
Journal:  Acta Physiol Scand       Date:  1963-05

10.  Appearance of 5-hydroxytryptamine and an unidentified pharmacologically active lipid acid in effluent from perfused cerebral ventricles.

Authors:  W Feldberg; R D Myers
Journal:  J Physiol       Date:  1966-06       Impact factor: 5.182

View more
  2 in total

1.  Central autonomic effects of prostaglandin F2 alpha on the cardiovascular system of the dog.

Authors:  H A Lavery; R D Lowe; G C Scroop
Journal:  Br J Pharmacol       Date:  1971-03       Impact factor: 8.739

2.  Serum-Based Oxylipins Are Associated with Outcomes in Primary Prevention Implantable Cardioverter Defibrillator Patients.

Authors:  Yiyi Zhang; Eliseo Guallar; Elena Blasco-Colmenares; Amy C Harms; Rob J Vreeken; Thomas Hankemeier; Gordon F Tomaselli; Alan Cheng
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.